Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany

BACKGROUND: Treatment of multidrug-resistant tuberculosis (MDR-TB) is complex, lengthy, and involves a minimum of four drugs termed a background regimen (BR), that have not previously been prescribed or that have proven susceptible to patient sputum culture isolates. In recent years, promising new t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirth, Daniel, Dass, Ramesh, Hettle, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341441/
https://www.ncbi.nlm.nih.gov/pubmed/28270207
http://dx.doi.org/10.1186/s12913-017-2118-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341441/
https://www.ncbi.nlm.nih.gov/pubmed/28270207
http://dx.doi.org/10.1186/s12913-017-2118-2

Ejemplares similares